Clinical Practice Guidelines (CPG) on EBMonFHIR
1.1.0 - qa-preview

This page is part of the CPG-on-EBMonFHIR Implementation Guide (1.1.0).

Example Evidence: Mortality Outcome for Dexamethasone application

Active as of 2025-01-24

Generated Narrative: Evidence DexamethasoneOutcomeMortality

url: Evidence ExampleOutcomeEvidence

name: ExampleOutcomeEvidence

status: Active

date: 2025-01-24 14:05:07+0000

RelatedArtifacts

-TypeResourceReference
*CitationCitation SystemicCorticosteroidsForTheTreatmentOfCOVID19

variableDefinition

variableRole: population

observed: Group StudyCohortCriteriaSystemicCorticosteroidsCOVID19

intended: EvidenceVariable StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

variableDefinition

variableRole: measured variable

observed: EvidenceVariable AllCauseMortality

synthesisType: not applicable

statistic

description:

Relative effect of intervention vs. comparator

statisticType: Relative Risk

quantity: 0.89

SampleSizes

-NumberOfStudiesNumberOfParticipants
*97930

AttributeEstimates

-TypeLevelRange
*Confidence interval0.950.8-1

statistic

description:

Baseline risk/result in the comparison group

statisticType: Incidence

quantity: 245 1/1000 (Details: UCUM code1/1000 = '1/1000')